4//SEC Filing
Garay Arpa 4
Accession 0001127602-23-029050
CIK 0001682852other
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 4:21 PM ET
Size
8.7 KB
Accession
0001127602-23-029050
Insider Transaction Report
Form 4
Moderna, Inc.MRNA
Garay Arpa
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2023-12-05+1,141→ 4,254 total - Sale
Common Stock
2023-12-06$78.34/sh−564$44,182→ 3,690 total - Exercise/Conversion
Restricted Stock Units
2023-12-05−1,141→ 11,405 total→ Common Stock (1,141 underlying)
Footnotes (3)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
- [F3]25% of the shares subject to this restricted stock unit award vested on June 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
Documents
Issuer
Moderna, Inc.
CIK 0001682852
Entity typeother
Related Parties
1- filerCIK 0001916360
Filing Metadata
- Form type
- 4
- Filed
- Dec 6, 7:00 PM ET
- Accepted
- Dec 7, 4:21 PM ET
- Size
- 8.7 KB